NYMC Faculty Publications

DOI

10.1177/2324709617732797

Journal Title

Journal of Investigative Medicine High Impact Case Reports

First Page

2324709617732797

Document Type

Article

Publication Date

9-1-2017

Department

Medicine

Abstract

Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consumptive thrombocytopenia, and microangiopathic hemolytic anemia, leading to end-organ ischemia and infarction, affecting particularly the kidney and brain. TMA is a pathological feature of a number of clinical disorders including thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and atypical hemolytic uremic syndrome. Rare but important, TMA may also occur in malignancy, connective tissue disease, malignant hypertension, and renal transplantation (rejection or drug toxicity). We present a very rare case where the patient developed acute kidney injury from TMA but found to have multiple myeloma as the possible underlying etiology.

Publisher's Statement

Originally published in Journal of Investigative Medicine High Impact Case Reports, 5 (3), 2324709617732797.

https://doi.org/10.1177/2324709617732797

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Included in

Nephrology Commons

Share

COinS